Relationship between erythrocyte-to-plasma distribution ratio of cyclosporin and lymphocyte Proliferation in renal transplant patients

European Journal of Clinical Pharmacology

Volumn 51, Issue 6, 1997, Pages 455-459

  Shibata, N ^a   Hoshino, N ^a   Minouchi, T ^a   Yamaji, A ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

Author keywords

Blood distribution; Cyclosporin; Lymphocyte proliferation; Pharmacokinetics; Renal transplantation; Stimulation index; Trough level monitoring

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG ERYTHROCYTE LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FLUOROMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; ALANINE TRANSAMINASE; CREATINE; CYCLOSPORINS; ERYTHROCYTES; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOGENS;

EID: 0030757921     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050230     Document Type: Article

References (18)

1. Rynasiewicz JJ, Sutherland DER, Ferguson RM, Squifflet JP, Morrow CE, Goetz FC, Najarian JS (1982) Cyclosporin A for immunosuppression: Observations in rat heart; pancreas and islet allograft models and in human renal and pancreas transplantation. Diabetes 31: 92-107
2. Laupacis A, Keown PA, Ulan RA, Mckenzie N, Stiller CR (1984) Cyclosporin A: A powerful immunosuppressant. Can Med Assoc J 126: 1041-1046
3. Cohen DJ, Loertscher R, Rubin MF, Tilmey NL, Capenter CB, Storm TB (1984) Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann Intern Med 101: 667 682
4. Lindholm A, Henricsson R (1989) Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants. Ther Drug Monit 11: 623-629
5. Tett S, Espinos E, Weekes L (1993) Who is ordering all those cyclosporin concentrations and how do they use them? An audit of cyclosporin therapeutic drug monitoring. Ther Drug Monit 15: 195-198
6. Shaw LM, Bower L, Demers L, Freeman D, Moyer T, Sanghvi A, Seltman H, Venkataramanan R (1987) Clinical issues in cyclosporine monitoring: report of the task force on cyclosporine monitoring. Clin Chem 33: 1269-1288
7. Shibata N, Shimakawa H, Minouchi T, Yamaji A (1993) Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease stales. Biol Pharm Bull 16: 1130-1135
8. Shibata N, Shimakawa H, Minouchi T, Yamaji A (1993) Erythrocyte uptake and protein binding of cyclosporin A (CyA) in human blood: Factors affecting CyA concentration in erythrocytes. Biol Pharm Bull 16: 702-707
9. Shibata N, Minouchi T, Hayashi Y, Shibata H, Ono T, Shimakawa H (1988) Blood-to-plasma distribution of cyclosporin A in a renal transplant recipient. Eur J Clin Pharmacol 35: 443-444
10. Shibata N, Minouchi T, Yamaji A, Park K, Inoue H, Tomoyoshi T, Sako H, Abe H, Kodama M (1994) Relationship between apparent total body clearance of cyclosporin A and its erythrocyte-to-plasma distribution ratio in renal transplant patients. Biol Pharm Bull 18: 115-121
11. Lefecq J, Paoletti C (1967) A fluorescence complex between ethidium bromide and nucleic acids. J Med Biol 27: 87-106
12. Vindelov L (1977) Flow microfluorimetric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch B Cell Pathol 24: 227-242
13. Abbott Laboratories Diagnostic Division (1984) TDx System Operation Manual. Abbott Laboratories, North Chicago
14. Shibata N, Minouchi T, Hayashi Y, Ono T, Shimakawa H (1987) Quantitative determination of cyclosporin A in whole blood and plasma by high performance liquid chromatography. Res Commun Chem Phathol Pharmacol 57: 261-271
15. Shibata N, Minouchi T, Ono T, Shimakawa H (1990) A model to account for the blood-to-plasma distribution of cyclosporin A in human blood. J Pharmacobio-Dyn 13: 20-29
16. Shibata N, Minouchi T, Hayashi Y, Shibata H, Ono T, Shimakawa H (1989) Effects of temperature and endogenous factors in blood on concentrations of cyclosporin in plasma measured by high performance liquid chromatography. Chem Pharm Bull 37: 1877-1880
17. Shibata N, Yamaji A, Park K, Tomoyoshi T, Sako H, Abe H, Kodama M, Nakane Y, Hodohara K, Hosoda S (1994) A simple method for predicting the cyclosporin A erythrocyte-to-plasma distribution ratio in blood, and its clinical assessment. Biol Pharm Bull 17: 709-714
18. Tamura K, Shibata Y, Matsuda Y, Ishida N (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Res 41: 3244-3252